Attend the premier hematology congress in Europe from June 13-16, 2019 in Amsterdam. 

The 24th Congress of EHA will offer you a program that includes every subspecialty in hematology, as well as networking opportunities with experts from all around the world.

The EHA Congress is a forum for original data, hematological innovation and evidence-based knowledge of primary clinical relevance. The congress also provides Satellite Symposia, Updates-in-Hematology and an exhibition organized by pharmaceutical companies, national and international non-profits. The program provides a comprehensive overview of hematology while still being easy to navigate. 

After six years, the EHA Annual Congress is coming back to The Netherlands. We are happy to come back to RAI Amsterdam, located only six minutes by train from Schiphol Airport and fifteen minutes from Amsterdam Central Station.

Congress objectives 

The EHA Annual Congress is a forum for

  • original unpublished data,
  • sharing ideas about hematological innovation, as well as for
  • disseminating evidence-based knowledge of primary clinical relevance.

Hematologists and affiliated professionals will be able to:

  • Enhance their knowledge of evidence-based approaches to diagnosis and treatment for hematologic diseases.
  • Access the latest results on clinical and translational research in hematologic disorders.
  • Be updated on emerging innovative techniques, diagnostic tools and risk-assessment strategies in hematology and its subspecialties.
  • Communicate, collaborate and network with representatives of a large international audience – medical professionals, national hematology societies, patient groups, medical industry and the media.

Congress center

The congress will take place at the RAI Amsterdam at Europaplein 24, 1078 GZ Amsterdam, The Netherlands.

For more info go to www.ehaweb.org

 

IPSS-R MDS Risk Assessment Calculator

Revised International Prognostic Scoring System (IPSS-R) for Myelodysplastic Syndromes Risk Assessment Calculator

calculator

Click here

MDS Fact Sheet

MDS Factsheet for GPs General Practicioners

MDS Fact Sheet

Click here

Varicella Vaccine in MDS

Urgent Clarification on varicella vaccine policy

Current advice from the UK MDS Forum is not to give the Live Varicella Vaccine to patients with MDS.

Please read below correspondence between Professor Salisbury and Dr George Follows, the latter on behalf of the CLL Forum, on the varicella vaccine policy.
This is an external link to the British Society for Haematology  Click here

NICE Guideline

Lenalidomide for treating myelodysplastic syndromes (MDS) associated with an isolated deletion 5q cytogenetic abnormality.

NICE logo

Click here

BSH Guidelines

This is an external link to the home of the British Society for Haematology (BSH). 

BSH Logo Strapline RGB

Click here